Products

MELAFIND
STRATA SKIN SCIENCES
Dermatology AI
MelaFind was an FDA-approved, software-driven optical imaging and data analysis device designed to provide dermatologists with additional information for deciding whether to biopsy irregular pigmented moles. The product was discontinued by Strata Skin Sciences in 2017.

See all 1 product →

About STRATA SKIN SCIENCES

STRATA Skin Sciences, Inc. is a medical technology company dedicated to developing, commercializing, and marketing innovative products for the in-office treatment of various dermatologic conditions. For physicians, STRATA offers a portfolio of advanced medical devices, primarily focusing on excimer laser and photopneumatic technologies. Their flagship products include the XTRAC® and Pharos excimer lasers, and VTRAC® lamp systems, which are utilized for targeted therapeutic treatment of chronic inflammatory and autoimmune skin conditions such as psoriasis, vitiligo, atopic dermatitis, eczema, and leukoderma.

The company also provides the TheraClear®X Acne Therapy System, which combines vacuum and broadband light to effectively address mild-to-moderate inflammatory, comedonal, and pustular acne. STRATA’s business model in the U.S. often involves a unique Partnership Program, offering a fee-per-treatment cost structure, on-site training, service, and marketing support to dermatology clinics. They also leverage direct-to-consumer marketing to generate patient awareness and drive appointment volume for their partner practices.

STRATA Skin Sciences emphasizes a personalized approach to treatment, with ongoing research and clinical studies supporting the efficacy of their devices, sometimes in combination with topical or systemic therapies. The company is actively working to expand Medicare and private payer coverage for its treatments, aiming to increase access for a broader patient population. While focused on advanced medical devices and solutions in dermatology, the provided information does not indicate that STRATA Skin Sciences is primarily a healthcare AI company.

Focus Areas

Dermatological conditions psoriasis vitiligo acne eczema atopic dermatitis leukoderma excimer laser therapy photopneumatic technology in-office treatments

Business Intelligence

Key InvestorsAccelmed, Ladenburg Thalmann & Co. Inc., MidCap Financial, LLC
PartnershipsCalifornia Skin Institute, Aqua Dermatology, Pennsylvania Dermatology Partners, Palo Alto Medical Foundation, MINO Labs (Mexico), Johns Hopkins Dermatology
AcquisitionsPhotoMedex Inc. (2015), Ra Medical Systems' U.S. dermatology business (2021), Theravant Corporation's TheraClear System (2022)
TechnologyExcimer laser technology (XTRAC, VTRAC, Pharos), photopneumatic technology (TheraClearX), microprocessor-controlled systems for dose monitoring
FDA ClearancesMultiple FDA 510(k) clearances for its product lines, including the XTRAC excimer laser (initial clearance 2000, expanded indications 2003, Multi-Micro Dose tip 2018, Momentum platform 2020), Pharos excimer lasers, and the TheraClear®X Acne Therapy System. cleared products (estimated)

What Physicians Need to Know

Specialized Dermatological Conditions
STRATA Skin Sciences specializes in the in-office treatment of a wide range of dermatological conditions, including psoriasis, vitiligo, acne, eczema, atopic dermatitis, leukoderma, alopecia areata, mycosis fungoides, lichen planus, and cutaneous T-cell lymphoma (CTCL).
Advanced Laser & Light Therapy
Their core technology includes the XTRACu00ae 308nm Excimer Laser and VTRACu00ae Excimer Lamp Systems, which deliver highly targeted therapeutic UVB light to affected skin areas while sparing healthy tissue.
Photopneumatic Acne Treatment
The TheraClearu00aeX Acne Therapy System utilizes photopneumatic technology, combining gentle vacuum with broadband light (500-1200nm) for effective, non-invasive treatment of mild-to-moderate inflammatory, comedonal, and pustular acne.
In-Office Treatment Focus
All treatments are designed for convenient in-office administration, offering quick, comfortable, and virtually painless procedures with no patient downtime, enhancing practice efficiency and patient satisfaction.
Physician Tip

For physicians, STRATA Skin Sciences stands out due to its commitment to personalized, evidence-based dermatologic care. The XTRACu00ae excimer laser offers a targeted, cost-effective alternative or adjunct to systemic immunosuppressants, with over 400 clinical publications supporting its efficacy and safety. The ability to integrate seamlessly with topical agents, biologics, and JAK inhibitors provides flexible treatment protocols. The TheraClearu00aeX system offers a unique, non-invasive option for acne with customizable settings for all skin types and visible improvements often seen as early as the second treatment. Furthermore, STRATA's unique Partnership Program eliminates upfront equipment purchase costs, offering a fee-per-treatment model that includes installation, on-site training, service, maintenance, and co-op advertising support, simplifying adoption and reducing financial burden for practices. Recent expansions in CPT codes for excimer laser treatments significantly broaden reimbursement eligibility for a wider array of inflammatory and autoimmune skin conditions, tripling the addressable patient population and improving treatment economics for providers. Their strong intellectual property portfolio ensures market exclusivity for combination therapies, providing confidence in their technology.

STRATA's technologies, particularly the XTRACu00ae excimer laser, are designed for seamless integration into existing dermatological treatment plans, complementing topical, systemic, biologic, and JAK inhibitor therapies to enhance patient outcomes. The TheraClearu00aeX system can be used effectively as monotherapy or in combination with topical or oral acne treatments. The Partnership Program further facilitates integration by providing comprehensive support, including training and maintenance, without requiring significant capital investment from the practice.

Products by STRATA SKIN SCIENCES

1 product in the directory

MELAFIND
STRATA SKIN SCIENCES
Dermatology AI
MelaFind was an FDA-approved, software-driven optical imaging and data analysis device designed to provide dermatologists with additional information for deciding whether to biopsy irregular pigmented moles. The product was discontinued by Strata Skin Sciences in 2017.

What the Web Says

STRATA Skin Sciences receives mixed reviews, with some employees citing a toxic work environment, lack of flexibility, and poor management, while others praise the staff, relaxed environment, and benefits. Product reviews for their skincare line (Stratia) are generally positive, with users appreciating the effectiveness and gentle formulations for various skin concerns. Their medical devices, such as TheraClearu00aeX for acne and XTRAC for psoriasis and vitiligo, have also shown positive results in studies and patient satisfaction.

Overall: Mixed

Strengths

  • Effective skincare products, particularly Liquid Gold and Interface Peptide Cream.
  • Gentle formulations suitable for sensitive skin.
  • TheraClearu00aeX and XTRAC devices are effective for treating acne, psoriasis, and vitiligo with high patient satisfaction.
  • Good customer service for their software products (Strata and StrataPT).
  • Some employees reported excellent staff, relaxed work environment, and great benefits.
  • Software products offer easy configuration, navigation, and data accessibility.

Limitations

  • Toxic work environment and poor management reported by some employees.
  • Lack of flexibility (must work on-site) and no equity/bonus/salary increases for some employees.
  • Issues with job security and advancement for some employees.
  • Some Stratia skincare products have a distinct smell that might not appeal to everyone.
  • Concerns about the financial stability of STRATA Skin Sciences, including Nasdaq delisting and loan default.
  • Implementation and onboarding challenges reported for Strata software.

Based on reviews from: Indeed, BioSpace, YouTube, Reddit, Junip, Capterra, StockTitan

Last updated: 2026-07-19

Videos

News, demos, and interviews about STRATA SKIN SCIENCES.

Loading videos...

Videos load interactively. If none appear, search YouTube for STRATA SKIN SCIENCES →

View all on YouTube

Press & Coverage

GlobeNewswire
New Peer-Reviewed Publication Confirms Unprecedented Response Rates for STRATA's Excimer Laser Combined with JAK Inhibitors in Pediatric Vitiligo
A new peer-reviewed study published in the Journal of the American Academy of Dermatology highlights that STRATA's 308-nm excimer laser, combined with oral JAK inhibitors, shows unprecedented repigmentation outcomes in pediatric vitiligo patients with a favorable safety profile.
2026-05
STRATA Skin Sciences Investor Relations
STRATA Skin Sciences Announces Exclusive Distribution Partnership with EKPAC Healthcare to Reestablish XTRACu00ae Leadership in China
STRATA Skin Sciences has partnered with EKPAC Healthcare for exclusive distribution of its XTRACu00ae products in China, aiming to reestablish market leadership in the region.
2026-06
GlobeNewswire
STRATA Skin Sciences Confirms Nasdaq Delisting
STRATA Skin Sciences announced its Nasdaq delisting, with trading suspended on February 19, 2026, and plans to 'go dark' to reduce reporting burdens and focus on operations.
2026-02
GlobeNewswire
STRATA Skin Sciences Highlights Meta-Analysis Confirming Clinical Efficacy of 308 nm Excimer Laser for Plaque Psoriasis
A February 2026 meta-analysis confirmed the clinical efficacy of 308 nm Excimer laser therapy for plaque psoriasis, showing significant PASI reductions.
2026-02
SSKN Latest News
Johns Hopkins Dermatology Expands Advanced Care for Inflammatory and Autoimmune Skin Conditions with Addition of XTRACu00ae Excimer Laser
Johns Hopkins Dermatology has added the XTRACu00ae Excimer Laser to its advanced care options for inflammatory and autoimmune skin conditions.
2026-02
BioSpace
STRATA Skin Sciences Showcases XTRACu00ae and TheraclearXu00ae at TeraCILAD 2025 u2014 Reports Early Adoption Momentum in Mexico
STRATA Skin Sciences presented its XTRACu00ae excimer laser and TheraclearXu00ae acne therapy system at TeraCILAD 2025, reporting growing adoption in Mexico with over 12 new recurring TheraclearXu00ae accounts by year-end 2025.
2025-12
Nasdaq
STRATA Skin Sciences Reinforces Market Leadership Following Key Litigation Milestones Against LaserOptek
STRATA Skin Sciences provided an update on its competitive positioning and ongoing litigation against LaserOptek, reaffirming the exclusive use of excimer lasers under specific CPT codes.
2025-10
GlobeNewswire
STRATA Skin Sciences Announces Closing of $2.42 Million Registered Direct Offering
STRATA Skin Sciences closed a registered direct offering, raising approximately $2.42 million in gross proceeds, which will be used for working capital and general corporate purposes.
2025-09

Frequently Asked Questions

STRATA SKIN SCIENCES' XTRAC excimer laser therapy is primarily used for chronic conditions such as psoriasis, vitiligo, leukoderma, and atopic dermatitis. Additionally, their TheraClearX photopneumatic technology is specifically designed for the in-office treatment of mild-to-moderate acne, including comedonal, pustular, and inflammatory acne vulgaris.
STRATA's in-office treatments, like the XTRAC excimer laser, offer targeted therapeutic light delivery to affected skin areas, minimizing exposure to healthy tissue and potentially reducing systemic side effects often associated with other therapies. This localized approach, coupled with the convenience of in-office sessions, can enhance patient adherence to treatment protocols for chronic conditions like psoriasis and vitiligo.
STRATA SKIN SCIENCES primarily offers a 'Partnership Program' in the U.S., which features a fee-per-treatment cost structure rather than requiring an outright equipment purchase. This model aims to provide dermatology practices with practical in-office treatment solutions, potentially increasing patient volume and creating new revenue streams without the need for significant upfront capital investment.
The XTRAC excimer laser is FDA-cleared and supported by over 150 clinical studies, with its efficacy for psoriasis, vitiligo, and atopic dermatitis recognized by organizations like the National Psoriasis Foundation. Similarly, the TheraClearX system is FDA-cleared for acne and has published clinical studies demonstrating its safety and effectiveness in reducing lesions and improving skin texture.
STRATA SKIN SCIENCES' Partnership Program includes comprehensive on-site training for practice personnel to ensure effective device utilization. They also provide ongoing service and maintenance for the equipment, dedicated account and customer service associates, and co-op advertising support to help practices raise awareness and promote their programs.
STRATA SKIN SCIENCES recently delisted from Nasdaq in February 2026, and their auditor has raised 'going concern' doubt, though the company stated the delisting was not due to financial instability. They aim to leverage these changes to enhance their leadership role in domestic and international markets by focusing on core operations and reducing reporting obligations.

Related Companies

e4health is a healthcare consulting and services company that provides innovative solutions to hospitals, health systems, outpatient providers, and physician practices. The company focuses on addressing data, quality, and revenue challenges within the healthcare ecosystem. Their services are designed to streamline health information data and workflows, optimize coding, quality, and clinical documentation integrity processes, and […]

PayZen is a healthcare AI company dedicated to solving the healthcare affordability crisis for both patients and providers. The company’s AI-powered platform offers personalized, interest-free, and fee-free patient financing solutions, enabling patients to manage their medical bills through affordable payment plans tailored to their unique ability to pay. This approach aims to increase access to […]

Healthcare Finance.AI is a company dedicated to leveraging cutting-edge artificial intelligence to optimize healthcare revenue cycles. Their goal is to improve financial outcomes for healthcare providers while simultaneously supporting the industry’s commitment to quality care and efficiency. They aim to achieve this by enhancing healthcare finance through AI innovation, demonstrating increased revenue cycle efficiency, reducing […]

The American Academy of Family Physicians (AAFP) is one of the largest national medical organizations in the United States, representing over 130,000 family physicians, residents, and medical students. Founded in 1947, its core mission is to improve the health of patients, families, and communities by serving the needs of its members with professionalism and creativity. […]

Imperial College Business School is a global business school that is part of Imperial College London, a top-ranking science-based institution. Established in 2004, the school integrates business and entrepreneurship with technology. Its roots in business education trace back to 1955 with an operational research/management science course. The school is triple-crown accredited (AACSB, AMBA, EQUIS), placing […]

Columbia University, through its online learning initiative ColumbiaX on edX, offers a range of courses, including those focused on healthcare AI. The university is a global leader in research, teaching, and public impact, consistently ranked among top universities. Their online offerings reflect a commitment to academic excellence and expanding access to high-quality education worldwide. For […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.